It's a good point tiger that we are so cheap in relation to our potential why bother partner with us when you could buy us with the same money. There was an interesting article on the CNN website about a week ago on HPV in the United States and the enormous impact it is having there. Could big pharma be waiting to see the data on the professor work before making a play. Some of these company's could buy us with loose change and pick up worlds best bio scaffold and emerging immunology platform in one hit.
It's a good point tiger that we are so cheap in relation to our...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.15 |
Change
0.000(0.00%) |
Mkt cap ! $291.2M | |||
| Open | High | Low | Value | Volume |
| $15.00 | $15.15 | $14.60 | $347.8K | 23.20K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 760 | $15.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.15 | 388 | 1 |
View Market Depth
| Last trade - 15.58pm 30/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |